Title
|
|
|
|
Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance
| |
Author
|
|
|
|
| |
Abstract
|
|
|
|
The immune system plays an instrumental role in obesity and insulin resistance. Here, we unravel the role of the costimulatory molecule CD40 and its signaling intermediates, TNF receptor-associated factors (TRAFs), in diet-induced obesity (DIO). Although not exhibiting increased weight gain, male CD40(-/-) mice in DIO displayed worsened insulin resistance, compared with wild-type mice. This worsening was associated with excessive inflammation of adipose tissue (AT), characterized by increased accumulation of CD8(+) T cells and M1 macrophages, and enhanced hepatosteatosis. Mice with deficient CD40-TRAF2/3/5 signaling in MHCII+ cells exhibited a similar phenotype in DIO as CD40(-/-) mice. In contrast, mice with deficient CD40-TRAF6 signaling in MHCII+ cells displayed no insulin resistance and showed a reduction in both AT inflammation and hepatosteatosis in DIO. To prove the therapeutic potential of inhibition of CD40-TRAF6 in obesity, DIO mice were treated with a small-molecule inhibitor that we designed to specifically block CD40-TRAF6 interactions; this compound improved insulin sensitivity, reduced AT inflammation, and decreased hepatosteatosis. Our study reveals that the CD40-TRAF2/3/5 signaling pathway in MHCII+ cells protects against AT inflammation and metabolic complications associated with obesity whereas CD40-TRAF6 interactions in MHCII+ cells aggravate these complications. Inhibition of CD40-TRAF6 signaling by our compound may provide a therapeutic option in obesity-associated insulin resistance. |
| |
Language
|
|
|
|
English
| |
Source (journal)
|
|
|
|
Proceedings of the National Academy of Sciences of the United States of America. - Washington, D.C.
| |
|
|
|
|
AMERICA
| |
Publication
|
|
|
|
Washington, D.C.
:
2014
| |
ISSN
|
|
|
|
0027-8424
[Print]
1091-6490
[Online]
| |
DOI
|
|
|
|
10.1073/PNAS.1400419111
| |
Volume/pages
|
|
|
|
111
:7
(2014)
, p. 2686-2691
| |
ISI
|
|
|
|
000331396500060
| |
Full text (Publisher's DOI)
|
|
|
|
| |
|